miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression

Kang,Min; Li,Yumei; Liu,Wenqi; Wang,Rensheng; Tang,Anzhou; Hao,Hong; Liu,Zhenguo; Ou,Hesheng

doi:10.3892/ijmm.2013.1384

miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression

Authors:
- Min Kang
- Yumei Li
- Wenqi Liu
- Rensheng Wang
- Anzhou Tang
- Hong Hao
- Zhenguo Liu
- Hesheng Ou
View Affiliations

Affiliations: The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, P.R. China, College of Pharmacy, Guangxi Medical University, Nanning, Guangxi, P.R. China, Davis Heart and Lung Research Institute and Division of Cardiovascular Medicine, The Ohio State University Medical Center, Columbus, OH, USA
Published online on: May 16, 2013 https://doi.org/10.3892/ijmm.2013.1384
Pages: 51-58

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We report the emerging role of microRNA (miRNA) deregulation associated with activation of an oncogene SOX4 (a member of the SRY-related HMG-box) in esophageal carcinoma. Paired esophageal cancer and adjacent non-tumor tissues were obtained from 42 patients who underwent primary surgical resection for esophageal cancer. Experiments such as real-time PCR, western blot analysis, luciferase-reporter assay, cell proliferation and colony formation assays, in vitro migration and invasion assays, and a wound-healing assay were performed to determine the effects of miR-129-2. We found that SOX4 expression was elevated (P<0.005) in esophageal tumors (n=42) when compared with its expression in the controls (n=42). Compared with the normal esophageal tissues, the expression of miR-129-2 was downregulated in 27 of 31 primary esophageal tumors, while the expression of SOX4 was upregulated (P<0.001). Restoration of miR-129-2 by transfection with an miRNA expression plasmid led to a decrease in SOX4 expression, which was accompanied by reduced migration and proliferation of the cancer cells. These results suggest that aberrant expression of SOX4 is associated with repression of miR-129-2, and restoration of miR-129-2 suppresses the migration and proliferation of esophageal cancer cells. Our results demonstrated that the deregulation of miR-129-2 leads to aberrant SOX4 expression, presenting a new paradigm in which the restoration of miRNA suppresses its oncogenic target in esophageal cancer.

View Figures

View References

1.	Dawsey SP, Tonui S, Parker RK, Fitzwater JW, Dawsey SM, White RE and Abnet CC: Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS One. 5:e140802010. View Article : Google Scholar : PubMed/NCBI
2.	Pramoonjago P, Baras AS and Moskaluk CA: Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene. 25:5626–5639. 2006. View Article : Google Scholar : PubMed/NCBI
3.	Medina PP, Castillo SD, Blanco S, et al: The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet. 18:1343–1352. 2009.PubMed/NCBI
4.	Liao YL, Sun YM, Chau GY, et al: Identification of SOX4 target genes using phylogenetic footprinting based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene. 27:5578–5589. 2008.
5.	Liu P, Ramachandran S, Ali Seyed M, et al: Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res. 66:4011–4019. 2006. View Article : Google Scholar : PubMed/NCBI
6.	Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML and Moreno CS: Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res. 69:709–717. 2009. View Article : Google Scholar : PubMed/NCBI
7.	Dy P, Penzo-Méndez A, Wang H, Pedraza CE, Macklin WB and Lefebvre V: The three SoxC proteins - Sox4, Sox11 and Sox12 - exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res. 36:3101–3117. 2008. View Article : Google Scholar : PubMed/NCBI
8.	Tavazoie SF, Alarcon C, Oskarsson T, et al: Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
9.	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Saito Y, Liang G, Egger G, et al: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
11.	Huang YW, Liu JC, Deatherage DE, et al: Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 69:9038–9046. 2009. View Article : Google Scholar : PubMed/NCBI
12.	Kulkarni S, Savan R, Qi Y, et al: Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature. 472:495–498. 2011.
13.	Wang LH, Kim SH, Lee JH, et al: Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res. 13:102–110. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Chern CJ and Beutler E: Biochemical and electrophoretic studies of erythrocyte pyridoxine kinase in white and black Americans. Am J Hum Genet. 28:9–17. 1976.
15.	Aaboe M, Birkenkamp-Demtroder K, Wiuf C, et al: SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res. 66:3434–3442. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Lee SH, Kunz J, Lin SH and Yu-Lee LY: 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Cancer Res. 67:11045–11053. 2007. View Article : Google Scholar : PubMed/NCBI
17.	van de Wetering M, Oosterwegel M, van Norren K and Clevers H: Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 12:3847–3854. 1993.PubMed/NCBI
18.	van Beest M, Dooijes D, van De Wetering M, et al: Sequence-specific high mobility group box factors recognize 10–12-base pair minor groove motifs. J Biol Chem. 275:27266–27273. 2000.PubMed/NCBI
19.	Wotton D, Lake RA, Farr CJ and Owen MJ: The high mobility group transcription factor, SOX4, transactivates the human CD2 enhancer. J Biol Chem. 270:7515–7522. 1995. View Article : Google Scholar : PubMed/NCBI
20.	Mu L, Berti L, Masserdotti G, et al: SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis. J Neurosci. 32:3067–3080. 2012. View Article : Google Scholar : PubMed/NCBI
21.	Zhang J, Liang Q, Lei Y, et al: SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res. 72:4597–4608. 2012. View Article : Google Scholar : PubMed/NCBI
22.	Kuwahara M, Yamashita M, Shinoda K, et al: The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses T(H)2 differentiation. Nat Immunol. 13:778–786. 2012.PubMed/NCBI
23.	Mavropoulos A, Devos N, Biemar F, et al: sox4b is a key player of pancreatic α cell differentiation in zebrafish. Dev Biol. 285:211–223. 2005. View Article : Google Scholar
24.	Pan X, Zhao J, Zhang WN, et al: Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci USA. 106:3788–3793. 2009. View Article : Google Scholar : PubMed/NCBI
25.	Ahn SG, Kim HS, Jeong SW, et al: Sox-4 is a positive regulator of Hep3B and HepG2 cells’ apoptosis induced by prostaglandin (PG)A(2) and Δ(12)-PGJ(2). Exp Mol Med. 34:243–249. 2002.PubMed/NCBI
26.	Hur EH, Hur W, Choi JY, et al: Functional identification of the pro-apoptotic effector domain in human Sox4. Biochem Biophys Res Commun. 325:59–67. 2004. View Article : Google Scholar : PubMed/NCBI
27.	Mikkers H, Allen J, Knipscheer P, et al: High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet. 32:153–159. 2002. View Article : Google Scholar : PubMed/NCBI
28.	Suzuki T, Shen H, Akagi K, et al: New genes involved in cancer identified by retroviral tagging. Nat Genet. 32:166–174. 2002. View Article : Google Scholar : PubMed/NCBI
29.	Ahn SG, Cho GH, Jeong SY, et al: Identification of cDNAs for Sox-4, an HMG-Box protein, and a novel human homolog of yeast splicing factor SSF-1 differentially regulated during apoptosis induced by prostaglandin A₂/Δ¹²-PGJ₂ in Hep3B cells. Biochem Biophys Res Commun. 260:216–221. 1999. View Article : Google Scholar : PubMed/NCBI
30.	Graham JD, Hunt SM, Tran N and Clarke CL: Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators. J Mol Endocrinol. 22:295–304. 1999. View Article : Google Scholar : PubMed/NCBI
31.	Lee CJ, Appleby VJ, Orme AT, et al: Differential expression of SOX4 and SOX11 in medulloblastoma. J Neurooncol. 57:201–214. 2002. View Article : Google Scholar : PubMed/NCBI
32.	Bangur CS, Switzer A, Fan L, et al: Identification of genes over-expressed in small cell lung carcinoma using suppression subtractive hybridization and cDNA microarray expression analysis. Oncogene. 21:3814–3825. 2002. View Article : Google Scholar
33.	Frierson HF Jr, El-Naggar AK, Welsh JB, et al: Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol. 161:1315–1323. 2002. View Article : Google Scholar : PubMed/NCBI
34.	Allegra A, Alonci A, Campo S, et al: Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). Int J Oncol. 41:1897–1912. 2012.PubMed/NCBI
35.	Mo MH, Chen L, Fu Y, Wang W and Fu SW: Cell-free circulating miRNA biomarkers in cancer. J Cancer. 3:432–448. 2012. View Article : Google Scholar : PubMed/NCBI
36.	Garzon R and Marcucci G: Potential of microRNAs for cancer diagnostics, prognostication and therapy. Curr Opin Oncol. 24:655–659. 2012. View Article : Google Scholar : PubMed/NCBI
37.	Zhao JJ, Yang J, Lin J, et al: Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 25:13–20. 2009. View Article : Google Scholar : PubMed/NCBI
38.	Shen R, Pan S, Qi S, Lin X and Cheng S: Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer. Biochem Biophys Res Commun. 394:1047–1052. 2010. View Article : Google Scholar : PubMed/NCBI
39.	Tsai KW, Wu CW, Hu LY, et al: Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer. 129:2600–2610. 2011. View Article : Google Scholar : PubMed/NCBI
40.	Bandres E, Agirre X, Bitarte N, et al: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI